“…In this context, many physical, chemical, and biological procedures for mycotoxin decontamination have been developed, most of which present limitations, such as high cost, complicated operation, low efficiency, and the activation of secondary metabolites toxic to humans and animals (Fashandi et al ., ). One of the most frequently employed procedures is the use of lactic acid bacteria (LAB) species that can adsorb mycotoxins from the contaminated media; the most accepted theory posits that a physical bind occurs between the mycotoxin and bacterial cell wall components, such as polysaccharides and peptidoglycans (Bovo et al ., ; Corassin et al ., ). Thus, different LAB species, especially those with GRAS status (Generally Recognized as Safe) and used as probiotics, have been studied in order to reduce the contamination and bioaccessibility of AFB 1 and AFM 1 in a model system and in milk (El Khoury, Atoui, & Yaghi, ; Elsanhoty, Salam, Ramadan, & Badr, ; Fazeli et al ., ; Khaneghah, Chaves, & Akbarirad, ; Pierides, El‐Nezami, Peltonen, Salminen, & Ahokas, ; Serrano‐Niño et al ., , ; Wochner et al ., ).…”